Drug intelligence / Profile preview

lacidipine + amlodipine

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Lacidipine + amlodipine is a combination of two dihydropyridine calcium channel blockers, both used primarily for the treatment of hypertension. Both drugs act by inhibiting L-type voltage-dependent calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure. Amlodipine also has antianginal effects and additional pleiotropic actions such as antioxidant activity and stimulation of nitric oxide production. Lacidipine is highly lipophilic with a slow onset of action, which may reduce reflex tachycardia and provide sustained antihypertensive effects. Both agents are well-tolerated and effective as once-daily oral therapies for mild-to-moderate hypertension[1][2][3][4][5][6].

02

Targets

CACNA1B (Voltage-dependent N-type calcium channel subunit alpha-1B)LTCC (Voltage-gated calcium channel (L-type))CaV3 (Caveolin-3)

Beyond the preview

Go deeper on lacidipine + amlodipine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lacidipine + amlodipine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call